Replimune (REPL) Interest Expenses (2017 - 2026)

Replimune (REPL) reported Interest Expenses of $259000.0 for Q1 2026, down 82.27% on a YoY basis from $1.5 million in Q1 2025, and down 99.38% sequentially from $41.6 million in Q4 2025.

Replimune (REPL) Interest Expenses (2017 - 2026) Analysis & Trends

Replimune (REPL) has 10 years of Interest Expenses data on file, last reported at $259000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Interest Expenses fell 82.27% year-over-year to $259000.0; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (up 22.75% YoY), and the FY2026 full-year result was $312.0 million, up 40.79% from the prior year.
  • Interest Expenses fell to $259000.0 in Q1 2026, from $41.6 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $51.0 million in Q2 2022 to a low of -$242000.0 in Q1 2022.
  • A 5-year average of $32.9 million and a median of $44.4 million in 2024 frame the typical range for Interest Expenses.
  • Across the five-year window, Interest Expenses plunged 103.82% in 2024 and surged 3846.15% in 2025, its largest moves.
  • Tracing REPL's Interest Expenses over 5 years: stood at $49.7 million in 2022, then decreased by 5.27% to $47.1 million in 2023, then fell by 5.73% to $44.4 million in 2024, then retreated by 6.26% to $41.6 million in 2025, then slumped by 99.38% to $259000.0 in 2026.
  • Business Quant data shows REPL's Interest Expenses at $259000.0 in Q1 2026, $41.6 million in Q4 2025, and $42.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -42,141.15
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 32.89 Mn
4 NuCana 279.75 Bn 279.75 Bn - 16.81 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.17 Bn
10 Replimune 970.73 Mn 970.73 Mn - 259,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 259,000.00
Mar 31, 2026 259,000.00
Dec 31, 2025 41.61 Mn
Dec 31, 2025 41.61 Mn
Sep 30, 2025 42.32 Mn
Sep 30, 2025 42.32 Mn
Jun 30, 2025 43.02 Mn
Jun 30, 2025 43.02 Mn
Mar 31, 2025 1.46 Mn
Mar 31, 2025 1.46 Mn
Dec 31, 2024 44.39 Mn
Dec 31, 2024 44.39 Mn
Sep 30, 2024 45.08 Mn
Sep 30, 2024 45.08 Mn
Jun 30, 2024 45.75 Mn
Jun 30, 2024 45.75 Mn
Mar 31, 2024 -39,000.00
Mar 31, 2024 -39,000.00
Dec 31, 2023 47.09 Mn
Dec 31, 2023 47.09 Mn